Nothing said here yet.
to join the conversation.
| FRANCISCO PARTNERS IV, L.P. | Sell | 439,310 | $1.5M | Wed, Aug 26 |
| FRANCISCO PARTNERS IV, L.P. | Sell | 433,088 | $1.5M | Wed, Aug 26 |
| FRANCISCO PARTNERS IV, L.P. | Sell | 213,401 | $749.6K | Wed, Aug 26 |
| FRANCISCO PARTNERS IV, L.P. | Sell | 210,378 | $739.0K | Wed, Aug 26 |
| FRANCISCO PARTNERS IV, L.P. | Sell | 64,090 | $220.8K | Tue, Aug 25 |
| FRANCISCO PARTNERS IV, L.P. | Sell | 63,183 | $217.7K | Tue, Aug 25 |
| FRANCISCO PARTNERS IV, L.P. | Sell | 72,309 | $250.3K | Mon, Aug 24 |
| FRANCISCO PARTNERS IV, L.P. | Sell | 71,285 | $246.8K | Mon, Aug 24 |
| FRANCISCO PARTNERS IV, L.P. | Sell | 138,338 | $483.7K | Fri, Aug 21 |
| FRANCISCO PARTNERS IV, L.P. | Sell | 136,379 | $476.9K | Fri, Aug 21 |
| FRANCISCO PARTNERS IV, L.P. | Sell | 233,415 | $821.7K | Thu, Aug 20 |
| FRANCISCO PARTNERS IV, L.P. | Sell | 213,844 | $752.8K | Thu, Aug 20 |
Nvidia’s nearly US$10b push into European AI gives smaller, financially disciplined businesses fresh ways to plug into powerful tech without building it all themselves. That matters for low priced shares where every dollar of capital counts.
What a fantastic six months it’s been for GoodRx. Shares of the company have skyrocketed 58.7%, hitting $3.29. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Amazon.com, Inc. (NASDAQ:AMZN) and GoodRx Holdings, Inc. (NASDAQ:GDRX) are signing up Americans for flat-fee prescription plans as health insurance coverage thins, according to a Reuters report on September 29.
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at GoodRx (NASDAQ:GDRX) and its peers.
GoodRx Holdings has delivered a steep 89.7% share price decline over the past five years.
GoodRx Holdings (GDRX) is back in focus after its Q2 2026 earnings report on 5 August, along with raised full-year revenue guidance and a leadership change that appoints Justin Fengler as Chief Financial Officer. See our latest analysis for GoodRx Holdings.